Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    

HOSPIRA, INC.
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensus 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Company
Hospira, Inc. provides injectable drugs and infusion technologies.Its offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services.The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL.  
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on HOSPIRA, INC.
2015HOSPIRA : Announces First Installation of Plum 360™ Infusion System With H..
PU
2015HOSPIRA : Announces First Installation of Plum 360(TM) Infusion System With Hosp..
PR
2015PFIZER : Buy of Hospira Gets Green Light
DJ
2015PFIZER : Gets U.S. Approval to Acquire Hospira, With Divestitures
DJ
2015HOSPIRA : Expert committee BACKS Hospira’s InflectraTM
PU
2015HOSPIRA : Charleston Area Medical Center Integrates Smart Pump Technology to Adv..
PR
2015HOSPIRA : TGA Approves First mAb Biosimilar
PR
2015HOSPIRA : Applauds UK's NICE for Issuing Adoption Resource to Help Drive the Int..
PU
2015PFIZER : Gets EU Green Light for Hospira Merger
DJ
2015HOSPIRA : Pfizer wins EU approval for $15 billion Hospira buy
RE
More news
Sector news : Generic Pharmaceuticals
03:50pAbbVie Gets FDA Priority Review for Imbruvica/Rituximab Combo
DJ
03:41pClamour for GSK shingles shot points to bigger profits
RE
03:28pPFIZER : breast cancer drug combo falls short of survival goal
RE
02:40pELI LILLY AND : Boehringer Ingelheim and Eli Lilly Say Diabetes Drug Meets Prima..
DJ
01:07pMERCK : FDA Accepts Keytruda SBLA as Adjuvant in Advanced Melanoma
DJ
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
HOSPIRA, INC. - 2013
End of the technical recovery
SELL
More Strategies
News from SeekingAlpha
2017Upcoming Events - Panel For Epogen Biosimilar And Ocaliva's Lipid Test For Na.. 
2016ABBOTT : Current Uncertainties Offer A Buying Opportunity 
2016New Management At ICU Medical Has Produced Positive Results 
2016PFIZER : 30%+ Discount With 4% Yield 
2015PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales 
Income Statement Evolution
Managers
NameTitle
Zena G. Kaufman Senior Vice President-Quality
Paul Greenland Vice President-Biologics
Sector and Competitors